摘要
流行病学资料表明非甾体类抗炎药(NSAIDs)和环氧合酶2(COX-2)抑制剂(昔布类)可以在许多人类肿瘤的化学预防和抗肿瘤方面发挥作用。在结肠癌中(CC),在这些分子的常规假设中已被证明有预防和治疗作用。自20世纪90年代末以来,已有逐步增加的实验证据表明CC非甾体抗炎药和昔布类的抗增殖作用可能是依赖和独立的COX抑制作用,而这些作用并不一定是相互排斥的。本文将探讨这些建立在环氧合酶基础上的细胞途径,并且着重研究那些通过转录因子串扰参与的抑制细胞增殖作用。
关键词: 结肠癌,炎症,非甾体抗炎药,增殖,转录因子,肿瘤。
Current Cancer Drug Targets
Title:Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition
Volume: 16 Issue: 2
Author(s): Tiziana Guarnieri
Affiliation:
关键词: 结肠癌,炎症,非甾体抗炎药,增殖,转录因子,肿瘤。
摘要: Epidemiological data suggest that Non Steroidal Anti Inflammatory Drugs (NSAIDs) and Cyclooxygenase 2 (COX2) inhibitors (COXibs) can exert chemopreventive and antitumour effects in many human neoplasia. This is particularly true in colon cancer (CC), where the regular assumption of these molecules has been shown to exert chemopreventive and chemotherapeutic effects. Since the late ‘90s, there has been a progressive increase in experimental evidence, indicating that in CC the antiproliferative effects of NSAIDs and COXibs could be both dependent on and independent of COXs inhibition, and that these effects do not necessarily exclude each other. This review will examine some of these COX-independent cellular pathways, with a focus on those involved in the inhibition of CC cells proliferation through transcription factors crosstalk.
Export Options
About this article
Cite this article as:
Tiziana Guarnieri , Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition, Current Cancer Drug Targets 2016; 16 (2) . https://dx.doi.org/10.2174/1568009615666150827093012
DOI https://dx.doi.org/10.2174/1568009615666150827093012 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial [Immunogenicity of Biotherapeutics: A Need for Consensus on Flexibility of Approach (Guest Editor: Stewart Barker)]
Current Drug Safety Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs: Regulators of TLR2-Mediated Probiotic Immune Responses
MicroRNA Mesalamine for Inflammatory Bowel Disease: Recent Reappraisals
Inflammation & Allergy - Drug Targets (Discontinued) Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies
Current Cancer Therapy Reviews Staphylococcus aureus: The Toxic Presence of a Pathogen Extraordinaire
Current Medicinal Chemistry In-Vitro Antiproliferative Activity of New Tetrahydroisoquinolines (THIQs) on Ishikawa Cells and their 3D Pharmacophore Models
Letters in Drug Design & Discovery Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals The Small Bowel: An Imaging Guide
Current Medical Imaging Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Approaches to Gastrointestinal Cytoprotection: From Isolated Cells, Via Animal Experiments to Healthy Human Subjects and Patients with Different Gastrointestinal Disorders
Current Pharmaceutical Design Lycopene Protects Liver Against Ulcerative Colitis
Current Drug Therapy Rational Design of CPP-based Drug Delivery Systems: Considerations from Pharmacokinetics
Current Pharmaceutical Biotechnology Equibiotic-GI Consumption Improves Intestinal Microbiota in Subjects with Functional Dyspepsia
Current Drug Therapy Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids
Current Cancer Drug Targets Ca<sup>2+</sup> Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
Current Vascular Pharmacology The Traces of Sound: Taking the Road to Skin
Current Rheumatology Reviews GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews Phosphoinositide 3-Kinases and Leukocyte Migration
Current Immunology Reviews (Discontinued)